A股異動 | 傲農生物(603363.SH)漲7% 力爭2023年實現1000萬頭出欄目標
格隆匯11月19日丨傲農生物(603363.SH)低位放量拉昇6.99%,報13.93元,日前曾創下8個月新低,暫成交2億元,總市值93.9億元。傲農生物日前舉辦投資者交流會,力爭2023年實現1000萬頭出欄目標。預計在2021年1月31日前,公司合作育肥的欄舍規模約為100萬頭,到明年6月末計劃達到150萬頭的合作欄舍規模。在飼料業務方面,今年的第三季度,傲農生物的飼料業務已基本完成轉型,預計今年全年飼料外銷銷量將突破200萬噸。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.